TSXV/CHS (TSXV/CHS)

TSX Venture Exchange: TSXV/CHS · CAD

CA$0.35

+0.00 (0.0%)· Recorded snapshot

Market cap	10.6M
Revenue (ttm)	6.2M
Net income (ttm)	-4M
EPS (ttm)	-CA$0.19
Shares out	30.2M
Volume	0
Beta	2.23

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 6.2M
Net income (ttm): -4M
EPS (ttm): -CA$0.19
Market cap: 10.6M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSXV/CHS indicators

Market & fundamental data

Available fields

159

Groups with data

Currency

USD

Showing 159 of 159 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-25
Enterprise value	CAD 11.9M
Exchange	TSX Venture Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2015
Industry	Health Information Services
Is primary listing	Yes
ISIN number	CA2046632071
Last earnings date	2025-11-25
Last refreshed	2026-10-28
Last stock split date	2025-05-12
Last stock split type	Reverse
Market cap	CAD 10.6M
Next earnings date	2026-11-25
Price	CAD 0.35
Price currency	CAD
Sector	Healthcare
SIC code	7370
Stock price date	2026-10-23
Symbol	tsxv/CHS
Website	https://comphealthcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-53.73%
EV/Sales	1.92x
FCF / EV yield	-33.02%
FCF yield	-37.3%
P/S ratio	1.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-54.31%
EBITDA margin	-54.16%
Gross margin	57.96%
Operating margin	-54.31%
Pretax margin	-64.71%
Profit margin	-65.28%
ROA	-83.13%
ROA (5Y)	-91.26%
ROCE	276.34%
SBC / revenue	10.37%
Tax / revenue	0.57%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	5.32%
Gross profit growth (Q)	8.51%
Gross profit growth 3Y	20.55%
Gross profit growth 5Y	4.12%
Net income growth years	0
Revenue growth	8.78%
Revenue growth (Q)	10.74%
Revenue growth (QoQ)	-2.38%
Revenue growth 3Y	3.16%
Revenue growth 5Y	-1.61%
Revenue growth quarters	2
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -287,381
Depreciation and amortization	CAD 9,352
EBIT	CAD -3.4M
EBITDA	CAD -3.4M
EPS	CAD -0.19
FCF per share	CAD -0.13
Financing cash flow	CAD 5.7M
Free cash flow	CAD -3.9M
Free cash flow minus SBC	CAD -4.6M
Gross profit	CAD 3.6M
Income taxes	CAD 35,302
Investing cash flow	CAD -139,300
Net borrowing	CAD -1.2M
Net cash flow	CAD 1.9M
Net income	CAD -4M
Operating cash flow minus SBC	CAD -4.3M
Operating income	CAD -3.4M
Revenue	CAD 6.2M
Stock-based compensation	CAD 643,578

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-15.09
Book value per share	CAD -0.11
Interest coverage	-10.82
Long-term assets	CAD 846,018
Long-term liabilities	CAD 2M
Net cash (debt)	CAD -1.4M
Net cash / market cap	-12.94%
Piotroski F-Score	2
Property, plant and equipment	CAD 741,596
Shareholders' equity	CAD -3.2M
Tangible book value	CAD -3.2M
Tangible book value per share	CAD -0.11
Total assets	CAD 3.7M
Total cash	CAD 2M
Total debt	CAD 3.4M
Total liabilities	CAD 6.9M
WACC	14.3%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	2.45
Current assets	CAD 2.8M
Current liabilities	CAD 4.9M
Current ratio	0.59
Net working capital	CAD -2.6M
Quick ratio	0.48
Working capital	CAD -2M
Working capital turnover	-1.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-19.99%
Shareholder yield	-19.99%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.55
1D price change	0%
1M price change	-12.5%
1M total return	-12.5%
1Y price change	-39.66%
1Y return CAGR	-39.68%
1Y total return	-39.66%
20-day SMA	CAD 0.38
200-day SMA	CAD 0.56
3M price change	-22.22%
3M total return	-22.22%
3Y price change	-12.5%
3Y return CAGR	-4.35%
3Y total return	-12.5%
50-day SMA	CAD 0.41
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.97
52-week high date	2026-04-08
52-week low	CAD 0.30
52-week low date	2026-10-07
5Y price change	-96.11%
5Y return CAGR	-47.77%
5Y total return	-96.11%
6M price change	-59.77%
6M total return	-59.77%
All-time high	CAD 9.00
All-time high date	2021-10-21
All-time low	CAD 0.10
All-time low date	2024-03-11
Average true range (ATR)	CAD 0.02
Average volume	8.9K
Beta (1Y)	0.47
Beta (2Y)	0.09
Beta (5Y)	2.23
Change from 52-week high	-63.92%
Change from 52-week low	16.67%
Change from all-time high	-96.11%
Change from all-time low	250%
Monthly RSI	37.8
Previous close	CAD 0.35
Price vs 150-day SMA	-36.93%
Price vs 20-day SMA	-7.24%
Price vs 200-day SMA	-37.03%
Price vs 50-day SMA	-14.97%
Relative volume	0.34
RSI	43.38
Sharpe ratio	1.21
Sortino ratio	2.36
Volume	0
Weekly RSI	40.81
YTD price change	-36.36%
YTD total return	-36.36%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	25.2M
Shares change (QoQ)	30.56%
Shares change (YoY)	19.99%
Shares held by insiders	16.38%
Shares outstanding	30.2M

Deeper analysis on TSXV/CHS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/CHS report

Is a complete TSXV/CHS research report available?

No complete published report is available for tsxv/CHS (TSXV/CHS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/CHS (TSXV/CHS)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/CHS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/CHS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSXV/CHS

Frequently asked questions